{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:59:08Z","timestamp":1792673948385,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T00:00:00Z","timestamp":1502150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T00:00:00Z","timestamp":1502150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hydroquinone (HQ) is one of the most frequently used and effective skin-lightening products to treat skin hyperpigmentation disorders, including postinflammatory hyperpigmentation, melasma and solar lentigines. HQ is also widely used in cosmetic products for skin whitening. However, HQ treatment can evoke substantial skin irritation, a side effect that remains poorly understood. Here we demonstrate that HQ is an activator of the peripheral irritant receptor transient receptor potential (TRP) cation channel member A1 (TRPA1). HQ failed to activate TRPV1, TRPV4 or TRPM8. HQ-induced TRPA1 activation was dependent on essential redox-sensitive cysteine and lysine residues within N-terminus of channel protein. HQ elicited Ca<jats:sup>2+<\/jats:sup> influx in a subpopulation of mouse sensory neurons sensitive to the TRPA1 agonist, mustard oil. HQ-induced neuronal responses were significantly reduced by TRPA1 inhibitors, and reduced in neurons isolated from Trpa1-deficient mice. In mice, intraplantar injection of HQ at clinically relevant concentrations elicited both acute pain and persistent mechanical hyperalgesia which were almost completely abolished by TRPA1 inhibitors. These findings identify TRPA1 as a molecular target for HQ and provide insights into the mechanism of HQ-induced skin irritation. These findings also suggest that selective TRPA1 antagonists may be useful to counteract HQ-induced skin irritation.<\/jats:p>","DOI":"10.1038\/s41598-017-07651-5","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T08:54:07Z","timestamp":1501664047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Involvement of Transient Receptor Potential Cation Channel Member A1 activation in the irritation and pain response elicited by skin-lightening reagent hydroquinone"],"prefix":"10.1038","volume":"7","author":[{"given":"Yan","family":"Tai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junying","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven-Eric","family":"Jordt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,8]]},"reference":[{"key":"7651_CR1","first-page":"109","volume":"79","author":"S Plensdorf","year":"2009","unstructured":"Plensdorf, S. & Martinez, J. Common pigmentation disorders. Am Fam Physician \n                           79, 109\u2013116 (2009).","journal-title":"Am Fam Physician"},{"key":"7651_CR2","first-page":"20","volume":"3","author":"EC Davis","year":"2010","unstructured":"Davis, E. C. & Callender, V. D. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol \n                           3, 20\u201331 (2010).","journal-title":"J Clin Aesthet Dermatol"},{"key":"7651_CR3","doi-asserted-by":"publisher","first-page":"232","DOI":"10.2340\/00015555-1225","volume":"92","author":"M Chandra","year":"2012","unstructured":"Chandra, M., Levitt, J. & Pensabene, C. A. Hydroquinone therapy for post-inflammatory hyperpigmentation secondary to acne: not just prescribable by dermatologists. Acta Derm Venereol \n                           92, 232\u2013235, doi:10.2340\/00015555-1225 (2012).","journal-title":"Acta Derm Venereol"},{"key":"7651_CR4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1529-8019.2007.00144.x","volume":"20","author":"ZD Draelos","year":"2007","unstructured":"Draelos, Z. D. Skin lightening preparations and the hydroquinone controversy. Dermatol Ther \n                           20, 308\u2013313, doi:10.1111\/j.1529-8019.2007.00144.x (2007).","journal-title":"Dermatol Ther"},{"key":"7651_CR5","first-page":"1","volume":"21","author":"B Sofen","year":"2016","unstructured":"Sofen, B., Prado, G. & Emer, J. Melasma and Post Inflammatory Hyperpigmentation: Management Update and Expert Opinion. Skin Therapy Lett \n                           21, 1\u20137 (2016).","journal-title":"Skin Therapy Lett"},{"key":"7651_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/ijd.13449","volume":"56","author":"M Lartey","year":"2017","unstructured":"Lartey, M. et al. Use of skin-lightening products among selected urban communities in Accra, Ghana. Int J Dermatol \n                           56, 32\u201339, doi:10.1111\/ijd.13449 (2017).","journal-title":"Int J Dermatol"},{"key":"7651_CR7","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3109\/09546630903341945","volume":"21","author":"TW Tse","year":"2010","unstructured":"Tse, T. W. Hydroquinone for skin lightening: safety profile, duration of use and when should we stop? J Dermatolog Treat \n                           21, 272\u2013275, doi:10.3109\/09546630903341945 (2010).","journal-title":"J Dermatolog Treat"},{"key":"7651_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/dsu.12296","volume":"40","author":"A Yousefi","year":"2014","unstructured":"Yousefi, A. et al. Is topical zinc effective in the treatment of melasma? A double-blind randomized comparative study. Dermatol Surg \n                           40, 33\u201337, doi:10.1111\/dsu.12296 (2014).","journal-title":"Dermatol Surg"},{"key":"7651_CR9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1365-2133.2008.08717.x","volume":"159","author":"R Chan","year":"2008","unstructured":"Chan, R. et al. A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma. Br J Dermatol \n                           159, 697\u2013703, doi:10.1111\/j.1365-2133.2008.08717.x (2008).","journal-title":"Br J Dermatol"},{"key":"7651_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1473-2165.2007.00301.x","volume":"6","author":"KA Smiles","year":"2007","unstructured":"Smiles, K. A. et al. A hydroquinone formulation with increased stability and decreased potential for irritation. J Cosmet Dermatol \n                           6, 83\u201388, doi:10.1111\/j.1473-2165.2007.00301.x (2007).","journal-title":"J Cosmet Dermatol"},{"key":"7651_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40264-015-0287-7","volume":"38","author":"L Barnes","year":"2015","unstructured":"Barnes, L., Kaya, G. & Rollason, V. Topical corticosteroid-induced skin atrophy: a comprehensive review. Drug Saf \n                           38, 493\u2013509, doi:10.1007\/s40264-015-0287-7 (2015).","journal-title":"Drug Saf"},{"key":"7651_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0278-6915(98)00127-6","volume":"37","author":"E Patrick","year":"1999","unstructured":"Patrick, E., Juberg, D. R., O\u2019Donoghue, J. & Maibach, H. I. Depigmentation with tert-butyl hydroquinone using black guinea pigs. Food Chem Toxicol \n                           37, 169\u2013175 (1999).","journal-title":"Food Chem Toxicol"},{"key":"7651_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-physiol-030212-183811","volume":"75","author":"DM Bautista","year":"2013","unstructured":"Bautista, D. M., Pellegrino, M. & Tsunozaki, M. TRPA1: A gatekeeper for inflammation. Annu Rev Physiol \n                           75, 181\u2013200, doi:10.1146\/annurev-physiol-030212-183811 (2013).","journal-title":"Annu Rev Physiol"},{"key":"7651_CR14","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1096\/fj.13-229948","volume":"27","author":"B Liu","year":"2013","unstructured":"Liu, B. et al. TRPA1 controls inflammation and pruritogen responses in allergic contact dermatitis. FASEB J \n                           27, 3549\u20133563, doi:10.1096\/fj.13-229948 (2013).","journal-title":"FASEB J"},{"key":"7651_CR15","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1172\/JCI34192","volume":"118","author":"BF Bessac","year":"2008","unstructured":"Bessac, B. F. et al. TRPA1 is a major oxidant sensor in murine airway sensory neurons. J Clin Invest \n                           118, 1899\u20131910, doi:10.1172\/JCI34192 (2008).","journal-title":"J Clin Invest"},{"key":"7651_CR16","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1096\/fj.08-117812","volume":"23","author":"BF Bessac","year":"2009","unstructured":"Bessac, B. F. et al. Transient receptor potential ankyrin 1 antagonists block the noxious effects of toxic industrial isocyanates and tear gases. FASEB J \n                           23, 1102\u20131114, doi:10.1096\/fj.08-117812 (2009).","journal-title":"FASEB J"},{"key":"7651_CR17","doi-asserted-by":"publisher","first-page":"e0165200","DOI":"10.1371\/journal.pone.0165200","volume":"11","author":"B Liu","year":"2016","unstructured":"Liu, B. et al. Oxidized Phospholipid OxPAPC Activates TRPA1 and Contributes to Chronic Inflammatory Pain in Mice. PLoS One \n                           11, e0165200, doi:10.1371\/journal.pone.0165200 (2016).","journal-title":"PLoS One"},{"key":"7651_CR18","doi-asserted-by":"publisher","first-page":"26894","DOI":"10.1038\/srep26894","volume":"6","author":"P Kanju","year":"2016","unstructured":"Kanju, P. et al. Small molecule dual-inhibitors of TRPV4 and TRPA1 for attenuation of inflammation and pain. Sci Rep \n                           6, 26894, doi:10.1038\/srep26894 (2016).","journal-title":"Sci Rep"},{"key":"7651_CR19","doi-asserted-by":"publisher","first-page":"28621","DOI":"10.1038\/srep28621","volume":"6","author":"K Kistner","year":"2016","unstructured":"Kistner, K. et al. Systemic desensitization through TRPA1 channels by capsazepine and mustard oil - a novel strategy against inflammation and pain. Sci Rep \n                           6, 28621, doi:10.1038\/srep28621 (2016).","journal-title":"Sci Rep"},{"key":"7651_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1744-8069-9-7","volume":"9","author":"S Miura","year":"2013","unstructured":"Miura, S. et al. Involvement of TRPA1 activation in acute pain induced by cadmium in mice. Mol Pain \n                           9, 7, doi:10.1186\/1744-8069-9-7 (2013).","journal-title":"Mol Pain"},{"key":"7651_CR21","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.cell.2006.02.023","volume":"124","author":"DM Bautista","year":"2006","unstructured":"Bautista, D. M. et al. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell \n                           124, 1269\u20131282, doi:10.1016\/j.cell.2006.02.023 (2006).","journal-title":"Cell"},{"key":"7651_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.cub.2014.01.013","volume":"24","author":"J Gui","year":"2014","unstructured":"Gui, J. et al. A tarantula-venom peptide antagonizes the TRPA1 nociceptor ion channel by binding to the S1-S4 gating domain. Curr Biol \n                           24, 473\u2013483, doi:10.1016\/j.cub.2014.01.013 (2014).","journal-title":"Curr Biol"},{"key":"7651_CR23","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nn1692","volume":"9","author":"H Xu","year":"2006","unstructured":"Xu, H., Delling, M., Jun, J. C. & Clapham, D. E. Oregano, thyme and clove-derived flavors and skin sensitizers activate specific TRP channels. Nat Neurosci \n                           9, 628\u2013635, doi:10.1038\/nn1692 (2006).","journal-title":"Nat Neurosci"},{"key":"7651_CR24","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1124\/jpet.104.079855","volume":"313","author":"NR Gavva","year":"2005","unstructured":"Gavva, N. R. et al. AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. J Pharmacol Exp Ther \n                           313, 474\u2013484, doi:10.1124\/jpet.104.079855 (2005).","journal-title":"J Pharmacol Exp Ther"},{"key":"7651_CR25","doi-asserted-by":"publisher","first-page":"E7572","DOI":"10.1073\/pnas.1606608113","volume":"113","author":"B Liu","year":"2016","unstructured":"Liu, B. et al. IL-33\/ST2 signaling excites sensory neurons and mediates itch response in a mouse model of poison ivy contact allergy. Proc Natl Acad Sci USA \n                           113, E7572\u2013E7579, doi:10.1073\/pnas.1606608113 (2016).","journal-title":"Proc Natl Acad Sci USA"},{"key":"7651_CR26","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1248\/bpb.26.1365","volume":"26","author":"T Matsubayashi","year":"2003","unstructured":"Matsubayashi, T. et al. Intradermal concentration of hydroquinone after application of hydroquinone ointments is higher than its cytotoxic concentration. Biol Pharm Bull \n                           26, 1365\u20131367 (2003).","journal-title":"Biol Pharm Bull"},{"key":"7651_CR27","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1038\/jid.2009.58","volume":"129","author":"R Atoyan","year":"2009","unstructured":"Atoyan, R., Shander, D. & Botchkareva, N. V. Non-neuronal expression of transient receptor potential type A1 (TRPA1) in human skin. J Invest Dermatol \n                           129, 2312\u20132315, doi:10.1038\/jid.2009.58 (2009).","journal-title":"J Invest Dermatol"},{"key":"7651_CR28","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1164\/rccm.201208-1358OC","volume":"187","author":"V Hox","year":"2013","unstructured":"Hox, V. et al. Crucial role of transient receptor potential ankyrin 1 and mast cells in induction of nonallergic airway hyperreactivity in mice. Am J Respir Crit Care Med \n                           187, 486\u2013493, doi:10.1164\/rccm.201208-1358OC (2013).","journal-title":"Am J Respir Crit Care Med"},{"key":"7651_CR29","doi-asserted-by":"publisher","first-page":"9099","DOI":"10.1073\/pnas.0900591106","volume":"106","author":"AI Caceres","year":"2009","unstructured":"Caceres, A. I. et al. A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma. Proc Natl Acad Sci USA \n                           106, 9099\u20139104, doi:10.1073\/pnas.0900591106 (2009).","journal-title":"Proc Natl Acad Sci USA"},{"key":"7651_CR30","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0092-8674(03)00158-2","volume":"112","author":"GM Story","year":"2003","unstructured":"Story, G. M. et al. ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell \n                           112, 819\u2013829 (2003).","journal-title":"Cell"},{"key":"7651_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-2133.2006.07376.x","volume":"155","author":"PM Plonka","year":"2006","unstructured":"Plonka, P. M., Handjiski, B., Michalczyk, D., Popik, M. & Paus, R. Oral zinc sulphate causes murine hair hypopigmentation and is a potent inhibitor of eumelanogenesis in vivo. Br J Dermatol \n                           155, 39\u201349, doi:10.1111\/j.1365-2133.2006.07376.x (2006).","journal-title":"Br J Dermatol"},{"key":"7651_CR32","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/j.1600-0625.2005.00365.x","volume":"14","author":"PM Plonka","year":"2005","unstructured":"Plonka, P. M., Handjiski, B., Popik, M., Michalczyk, D. & Paus, R. Zinc as an ambivalent but potent modulator of murine hair growth in vivo- preliminary observations. Exp Dermatol \n                           14, 844\u2013853, doi:10.1111\/j.1600-0625.2005.00365.x (2005).","journal-title":"Exp Dermatol"},{"key":"7651_CR33","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nchembio.146","volume":"5","author":"H Hu","year":"2009","unstructured":"Hu, H., Bandell, M., Petrus, M. J., Zhu, M. X. & Patapoutian, A. Zinc activates damage-sensing TRPA1 ion channels. Nat Chem Biol \n                           5, 183\u2013190, doi:10.1038\/nchembio.146 (2009).","journal-title":"Nat Chem Biol"},{"key":"7651_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.cyto.2015.01.034","volume":"74","author":"J Zhou","year":"2015","unstructured":"Zhou, J., Feng, J. Y., Wang, Q. & Shang, J. Calcitonin gene-related peptide cooperates with substance P to inhibit melanogenesis and induces apoptosis of B16F10 cells. Cytokine \n                           74, 137\u2013144, doi:10.1016\/j.cyto.2015.01.034 (2015).","journal-title":"Cytokine"},{"key":"7651_CR35","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1016\/j.biocel.2012.09.025","volume":"44","author":"F Ping","year":"2012","unstructured":"Ping, F., Shang, J., Zhou, J., Song, J. & Zhang, L. Activation of neurokinin-1 receptor by substance P inhibits melanogenesis in B16-F10 melanoma cells. Int J Biochem Cell Biol \n                           44, 2342\u20132348, doi:10.1016\/j.biocel.2012.09.025 (2012).","journal-title":"Int J Biochem Cell Biol"},{"key":"7651_CR36","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1600-0749.1988.tb00140.x","volume":"1","author":"CJ Smith","year":"1988","unstructured":"Smith, C. J., O\u2019Hare, K. B. & Allen, J. C. Selective cytotoxicity of hydroquinone for melanocyte-derived cells is mediated by tyrosinase activity but independent of melanin content. Pigment Cell Res \n                           1, 386\u2013389 (1988).","journal-title":"Pigment Cell Res"},{"key":"7651_CR37","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S0076-6879(04)78005-2","volume":"378","author":"EJ Land","year":"2004","unstructured":"Land, E. J., Ramsden, C. A. & Riley, P. A. Quinone chemistry and melanogenesis. Methods Enzymol \n                           378, 88\u2013109, doi:10.1016\/S0076-6879(04)78005-2 (2004).","journal-title":"Methods Enzymol"},{"key":"7651_CR38","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1152\/physrev.00044.2003","volume":"84","author":"A Slominski","year":"2004","unstructured":"Slominski, A., Tobin, D. J., Shibahara, S. & Wortsman, J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev \n                           84, 1155\u20131228, doi:10.1152\/physrev.00044.2003 (2004).","journal-title":"Physiol Rev"},{"key":"7651_CR39","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1473-2165.2006.00253.x","volume":"5","author":"JL O\u2019Donoghue","year":"2006","unstructured":"O\u2019Donoghue, J. L. Hydroquinone and its analogues in dermatology - a risk-benefit viewpoint. J Cosmet Dermatol \n                           5, 196\u2013203, doi:10.1111\/j.1473-2165.2006.00253.x (2006).","journal-title":"J Cosmet Dermatol"},{"key":"7651_CR40","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4103\/0378-6323.178903","volume":"82","author":"AB Mehta","year":"2016","unstructured":"Mehta, A. B. et al. Topical corticosteroids in dermatology. Indian J Dermatol Venereol Leprol \n                           82, 371\u2013378, doi:10.4103\/0378-6323.178903 (2016).","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"7651_CR41","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1096\/fj.11-188383","volume":"25","author":"DN Willis","year":"2011","unstructured":"Willis, D. N., Liu, B., Ha, M. A., Jordt, S. E. & Morris, J. B. Menthol attenuates respiratory irritation responses to multiple cigarette smoke irritants. FASEB J \n                           25, 4434\u20134444, doi:10.1096\/fj.11-188383 (2011).","journal-title":"FASEB J"},{"key":"7651_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0165-0270(99)00004-7","volume":"87","author":"GM Pitcher","year":"1999","unstructured":"Pitcher, G. M., Ritchie, J. & Henry, J. L. Paw withdrawal threshold in the von Frey hair test is influenced by the surface on which the rat stands. J Neurosci Methods \n                           87, 185\u2013193 (1999).","journal-title":"J Neurosci Methods"},{"key":"7651_CR43","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/j.pain.2013.06.043","volume":"154","author":"B Liu","year":"2013","unstructured":"Liu, B. et al. TRPM8 is the principal mediator of menthol-induced analgesia of acute and inflammatory pain. Pain \n                           154, 2169\u20132177, doi:10.1016\/j.pain.2013.06.043 (2013).","journal-title":"Pain"},{"key":"7651_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13760","author":"AI Caceres","year":"2017","unstructured":"Caceres, A. I. et al. Transient Receptor Potential Cation Channel Subfamily M Member 8 channels mediate the anti-inflammatory effects of eucalyptol. Br J Pharmacol., doi:10.1111\/bph.13760 (2017).","journal-title":"Br J Pharmacol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07651-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07651-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07651-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T08:15:10Z","timestamp":1671783310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07651-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,8]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["7651"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-07651-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,8]]},"assertion":[{"value":"23 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Sven-Eric Jordt serves on the Scientific Advisory Board of Hydra Biosciences LLC (Cambridge, MA), a biopharmaceutical company developing TRP ion channel inhibitors for the treatment of pain and inflammation. All other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7532"}}